3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
15
Phase 1/2
10
Phase 2
9
Phase 1
5
Phase NA
2
Phase 4
1
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Breast Neoplasms
406
Neoplasms
367
Prostatic Neoplasms
194
Lung Neoplasms
185
Colorectal Neoplasms
136
Motor Activity
84
Pancreatic Neoplasms
77
Uterine Cervical Neoplasms
74
Carcinoma, Non-Small-Cell Lung
72
Head and Neck Neoplasms
67
Brain Neoplasms
67
Ovarian Neoplasms
59
Carcinoma, Hepatocellular
50
Neoplasm Metastasis
48
Rectal Neoplasms
46
Colonic Neoplasms
45
Anxiety Disorders
45
Precursor Cell Lymphoblastic Leukemia-Lymphoma
43
Hematologic Neoplasms
39
Depression
38
Melanoma
36
Glioblastoma
35
Glioma
34
Disease
34
Multiple Myeloma
33
Sarcoma
32
Gastrointestinal Neoplasms
32
Urinary Bladder Neoplasms
31
Stomach Neoplasms
31
Pain
31
Interventions
chondroitin sulfate, sodium hyaluronate drug combination
1
Hyaluronic Acid
1
Chondroitin Sulfates
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Non-Muscle Invasive Bladder Neoplasms
×
90 days
×
Clear all
NCT07231809
2026-05-06
HIVEC
AC.TA. S.r.l.
Phase NA
Not yet recruiting
50 enrolled
NCT07495072
2026-03-27
PRO-GAG
BLAD-HYA Group
Phase NA
Recruiting
56 enrolled